Izzo T - Search Results

1

Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Muccioli G, Viola A, Pane F, Palmieri S. Ferrara F, et al. Among authors: izzo t. Biol Blood Marrow Transplant. 2010 Jul;16(7):1018-24. doi: 10.1016/j.bbmt.2010.02.011. Epub 2010 Feb 19. Biol Blood Marrow Transplant. 2010. PMID: 20172040 Free article.

2

Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.

Ferrara F, Palmieri S, Pedata M, Viola A, Izzo T, Criscuolo C, Mele G. Ferrara F, et al. Among authors: izzo t. Hematol Oncol. 2009 Mar;27(1):40-5. doi: 10.1002/hon.893. Hematol Oncol. 2009. PMID: 19206083

3

Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.

Ferrara F, Mele G, Palmieri S, Pedata M, Copia C, Riccardi C, Izzo T, Criscuolo C, Musto P. Ferrara F, et al. Among authors: izzo t. Hematol Oncol. 2009 Dec;27(4):198-202. doi: 10.1002/hon.903. Hematol Oncol. 2009. PMID: 19475701 Clinical Trial.

4

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Celentano M, Mele G. Ferrara F, et al. Among authors: izzo t. Am J Hematol. 2010 Sep;85(9):687-90. doi: 10.1002/ajh.21791. Am J Hematol. 2010. PMID: 20652967 Free article.

5

Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.

Ferrara F, Finizio O, Izzo T, Riccardi C, Criscuolo C, Carbone A, Borlenghi E, Rossi G. Ferrara F, et al. Among authors: izzo t. Anticancer Res. 2010 Sep;30(9):3845-9. Anticancer Res. 2010. PMID: 20944181

6

Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.

Ferrara F, Palmieri S, Izzo T, Criscuolo C, Riccardi C. Ferrara F, et al. Among authors: izzo t. Hematol Oncol. 2010 Dec;28(4):202-8. doi: 10.1002/hon.943. Hematol Oncol. 2010. PMID: 21136583 Clinical Trial.

7

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Viola A, Delia R, Carbone A, Celentano M. Ferrara F, et al. Among authors: izzo t. Hematol Oncol. 2011 Sep;29(3):139-43. doi: 10.1002/hon.978. Epub 2010 Nov 30. Hematol Oncol. 2011. PMID: 21922508 Clinical Trial.

8

FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.

Ferrara F, Criscuolo C, Riccardi C, Izzo T, Pedata M, Copia C, Vicari L, Tarsitano M, Palmieri S, Pane F. Ferrara F, et al. Among authors: izzo t. Am J Hematol. 2009 Aug;84(8):532-5. doi: 10.1002/ajh.21458. Am J Hematol. 2009. PMID: 19562748 Free article. No abstract available.

9

HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.

Lepore I, Dell'Aversana C, Pilyugin M, Conte M, Nebbioso A, De Bellis F, Tambaro FP, Izzo T, Garcia-Manero G, Ferrara F, Irminger-Finger I, Altucci L. Lepore I, et al. Among authors: izzo t. PLoS One. 2013 Dec 11;8(12):e83018. doi: 10.1371/journal.pone.0083018. eCollection 2013. PLoS One. 2013. PMID: 24349422 Free PMC article.

10

High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

Caivano A, Laurenzana I, De Luca L, La Rocca F, Simeon V, Trino S, D'Auria F, Traficante A, Maietti M, Izzo T, D'Arena G, Mansueto G, Pietrantuono G, Laurenti L, Musto P, Del Vecchio L. Caivano A, et al. Among authors: izzo t. Tumour Biol. 2015 Dec;36(12):9739-52. doi: 10.1007/s13277-015-3741-3. Epub 2015 Jul 9. Tumour Biol. 2015. PMID: 26156801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page